Cel-Sci
CVM
#9766
Rank
C$71.27 M
Marketcap
C$8.92
Share price
2.54%
Change (1 day)
-67.18%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -C$34.61 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$36.73 Million, an increase over its 2023 earnings that were of -C$41.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$34.61 Million-5.76%
2024 -C$36.73 Million-12.41%
2023 -C$41.93 Million-12.87%
2022 -C$48.13 Million-3.42%
2021 -C$49.83 Million13.44%
2020 -C$43.93 Million11.28%
2019 -C$39.48 Million179.81%
2018 -C$14.11 Million-48.72%
2017 -C$27.51 Million-16.23%
2016 -C$32.84 Million-23.63%
2015 -C$43.01 Million-5.47%
2014 -C$45.49 Million198.49%
2013 -C$15.25 Million
2010 -C$17.79 Million
2004 -C$6.02 Million12.38%
2003 -C$5.35 Million-16.59%
2002 -C$6.42 Million-59.28%
2001 -C$15.75 Million23.17%
2000 -C$12.79 Million20.12%
1999 -C$10.65 Million13.24%
1998 -C$9.41 Million-20%
1997 -C$11.76 Million46.55%
1996 -C$8.02 Million34.88%
1995 -C$5.95 Million2.38%
1994 -C$5.81 Million68%
1993 -C$3.46 Million78.57%
1992 -C$1.94 Million180%
1991 -C$0.7 Million25%
1990 -C$0.56 Million-0%
1989 -C$0.56 Million-71.43%
1988 -C$1.94 Million-0%
1987 -C$1.94 Million-46.15%
1986 -C$3.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Curis
CRIS
-C$45.01 Million 31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-C$9.15 Million-73.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.39 B-33,443.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-C$0.2 Billion 458.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$2.44 B-7,266.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
C$44.78 B-131,127.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.22 B-768.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$13.12 Million-61.62%๐Ÿ‡บ๐Ÿ‡ธ USA